Gritstone Bio Can Tap $25M New DIP As It Works Toward Sale

By Alex Wittenberg · November 13, 2024, 4:27 PM EST

Vaccine developer Gritstone bio Inc. won a Delaware bankruptcy judge's approval Wednesday to borrow $25 million in new financing to support itself in Chapter 11 as the biotechnology company works to...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

A vaccine developer focused on preventative treatments for cancer and HIV filed for bankruptcy with plans to find a buyer in Chapter 11 that will continue its research.

Case Number

24-bk-12305

Judge

Karen Owens

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$100 million to $500 million

View Full Scorecard

Related Sections

Case Information

Case Title

Gritstone bio, Inc.

Case Number

1:24-bk-12305

Court

Delaware

Nature of Suit

Date Filed

October 10, 2024

Recent Articles By Alex